187 related articles for article (PubMed ID: 12036450)
1. Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas.
Shigemasa K; Katoh O; Shiroyama Y; Mihara S; Mukai K; Nagai N; Ohama K
Jpn J Cancer Res; 2002 May; 93(5):542-50. PubMed ID: 12036450
[TBL] [Abstract][Full Text] [Related]
2. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
Baekelandt M; Holm R; Nesland JM; Tropé CG; Kristensen GB
J Clin Oncol; 2000 Nov; 18(22):3775-81. PubMed ID: 11078490
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
4. Developmental changes in expression of myeloid cell leukemia-1 in human germ cells during oogenesis and early folliculogenesis.
Hartley PS; Bayne RA; Robinson LL; Fulton N; Anderson RA
J Clin Endocrinol Metab; 2002 Jul; 87(7):3417-27. PubMed ID: 12107261
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of bcl-2, bax, mcl-1, and bcl-X expression in ovarian surface epithelial tumors.
Wehrli BM; Krajewski S; Gascoyne RD; Reed JC; Gilks CB
Int J Gynecol Pathol; 1998 Jul; 17(3):255-60. PubMed ID: 9656122
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers.
Miyamoto Y; Hosotani R; Wada M; Lee JU; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Doi R; Kato M; Shimada Y; Imamura M
Oncology; 1999; 56(1):73-82. PubMed ID: 9885381
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska M; Krajewski S; Epstein JI; Shabaik A; Sauvageot J; Song K; Kitada S; Reed JC
Am J Pathol; 1996 May; 148(5):1567-76. PubMed ID: 8623925
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of Bcl-2 related proteins in human ovarian cancers.
Witty JP; Jensen RA; Johnson AL
Anticancer Res; 1998; 18(2B):1223-30. PubMed ID: 9615792
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.
Krajewski S; Krajewska M; Ehrmann J; Sikorska M; Lach B; Chatten J; Reed JC
Am J Pathol; 1997 Mar; 150(3):805-14. PubMed ID: 9060818
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer.
Gu L; Shigemasa K; Ohama K
Int J Oncol; 2004 Mar; 24(3):671-8. PubMed ID: 14767552
[TBL] [Abstract][Full Text] [Related]
11. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
12. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
13. Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer.
Shigemasa K; Gu L; Tanimoto H; O'Brien TJ; Ohama K
Clin Cancer Res; 2004 Apr; 10(8):2766-70. PubMed ID: 15102682
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the antiapoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1) and the stimulation of its message by gonadotropins in the rat ovary.
Leo CP; Hsu SY; Chun SY; Bae HW; Hsueh AJ
Endocrinology; 1999 Dec; 140(12):5469-77. PubMed ID: 10579309
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2: bax and bcl-2: Bcl-x ratios by image cytometric quantitation of immunohistochemical expression in ovarian carcinoma: correlation with prognosis.
Lohmann CM; League AA; Clark WS; Lawson D; DeRose PB; Cohen C
Cytometry; 2000 Feb; 42(1):61-6. PubMed ID: 10679744
[TBL] [Abstract][Full Text] [Related]
16. Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas.
Shigemasa K; Shiroyama Y; Sawasaki T; Fujii T; Nagai N; Parmley TH; O'Brien TJ; Ohama K
Int J Oncol; 2001 May; 18(5):953-8. PubMed ID: 11295040
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer.
Marx D; Binder C; Meden H; Lenthe T; Ziemek T; Hiddemann T; Kuhn W; Schauer A
Anticancer Res; 1997; 17(3C):2233-40. PubMed ID: 9216694
[TBL] [Abstract][Full Text] [Related]
18. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.
Diebold J; Baretton G; Felchner M; Meier W; Dopfer K; Schmidt M; Löhrs U
Am J Clin Pathol; 1996 Mar; 105(3):341-9. PubMed ID: 8602616
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma.
Virkajärvi N; Pääkkö P; Soini Y
Histopathology; 1998 Nov; 33(5):432-9. PubMed ID: 9839167
[TBL] [Abstract][Full Text] [Related]
20. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
Deininger MH; Weller M; Streffer J; Meyermann R
Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
